Amy H. Huang/X
Dec 9, 2025, 08:02
Amy H. Huang: Our Work on Bone Health in Myeloma Has Been Recognized with ASH Abstract Achievement Award
Amy H. Huang, Internal Medicine Resident Physician at University of Connecticut, posted on X:
“Excited to share our work at ASH! This is a bi-institutional study (UConn and Yale) on bone health in myeloma that has been recognized with ASH Abstract Achievement Award.
- Delays in dental screening is a major contributor to guideline nonadherence of bone-modifying agent (BMA) prescriptions. Opportunity for QI initiatives to streamline the process.
- Only around 56% of BMA prescriptions were fully concordant with the IMWG guidelines.
- The occurrence of skeletal events were also found to be similar between patients who received more than 5 years of BMA versus less than 5 years. This raises the question of whether prolonged use of BMA really confers benefit and further research is needed.
Managing morbidities is as important as treating the malignancy itself. Sometimes this is what patients care about the most.”
Get the latest from Hemostasis Today.
-
Jan 24, 2026, 15:54Nicolas Nesseler on How Common and Serious is Post-Op Bleeding After Heart Transplantation
-
Jan 24, 2026, 15:43Roey Tagansky on Tu Youyou and the Rediscovery That Defeated Malaria
-
Jan 24, 2026, 15:27Mavis Agnes Kisakye on Community Impact at HFU
-
Jan 24, 2026, 15:15Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
-
Jan 24, 2026, 15:02Todd Davenport on The Impacts of Long COVID
-
Jan 24, 2026, 14:47Seth D Ginsberg: Last Month, Something Meaningful Happened in Tokyo
-
Jan 24, 2026, 14:33Heghine Khachatryan on New Insights Into Bleeding Mechanisms in Acquired Hemophilia A
-
Jan 24, 2026, 14:21Mamta Soni Shares Highlights from CBC Chennai 2026
-
Jan 24, 2026, 13:52Larysa Mykhailova on Characterization of Allogeneic Platelet Gel